Spots Global Cancer Trial Database for small molecule kinase inhibitor
Every month we try and update this database with for small molecule kinase inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body | NCT04187456 | Solid Tumors | Savolitinib Midazolam | 18 Years - 65 Years | AstraZeneca | |
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib | NCT05948462 | Lung Cancer Non-small Cell ... | Lorlatinib Cisplatin or Ca... Pemetrexed | 18 Years - | SCRI Development Innovations, LLC | |
A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine | NCT04179071 | Solid Tumours | Savolitinib Famotidine | 18 Years - 65 Years | AstraZeneca | |
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib | NCT05948462 | Lung Cancer Non-small Cell ... | Lorlatinib Cisplatin or Ca... Pemetrexed | 18 Years - | SCRI Development Innovations, LLC |